EZH2 and medulloblastoma: In liver and kidney malignancies, alternative EZH2 variants have been shown to contribute to tumorigenic potential [25,26]; however, in medulloblastoma, which EZH2 variants are expressed and what their potential impact on the disease has not been studied.